JP2010539160A5 - - Google Patents

Download PDF

Info

Publication number
JP2010539160A5
JP2010539160A5 JP2010524811A JP2010524811A JP2010539160A5 JP 2010539160 A5 JP2010539160 A5 JP 2010539160A5 JP 2010524811 A JP2010524811 A JP 2010524811A JP 2010524811 A JP2010524811 A JP 2010524811A JP 2010539160 A5 JP2010539160 A5 JP 2010539160A5
Authority
JP
Japan
Prior art keywords
methyl
optionally substituted
pharmaceutically acceptable
hydrate
carbethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010524811A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010539160A (ja
Filing date
Publication date
Priority claimed from RU2007134267/15A external-priority patent/RU2361581C2/ru
Application filed filed Critical
Publication of JP2010539160A publication Critical patent/JP2010539160A/ja
Publication of JP2010539160A5 publication Critical patent/JP2010539160A5/ja
Pending legal-status Critical Current

Links

JP2010524811A 2007-09-14 2008-05-22 抗糖尿病作用を備える医薬組成物 Pending JP2010539160A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2007134267/15A RU2361581C2 (ru) 2007-09-14 2007-09-14 Фармацевтическая композиция, обладающая противодиабетической, гиполипидемической, гипогликемической и гипохолестеринемической активностью, способ ее получения и способы лечения указанных заболеваний
PCT/RU2008/000320 WO2009035368A1 (en) 2007-09-14 2008-05-22 Antidiabetic pharmaceutical composition

Publications (2)

Publication Number Publication Date
JP2010539160A JP2010539160A (ja) 2010-12-16
JP2010539160A5 true JP2010539160A5 (https=) 2011-07-07

Family

ID=40452228

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010524811A Pending JP2010539160A (ja) 2007-09-14 2008-05-22 抗糖尿病作用を備える医薬組成物

Country Status (11)

Country Link
US (1) US8247407B2 (https=)
EP (1) EP2204173B1 (https=)
JP (1) JP2010539160A (https=)
KR (1) KR20100086981A (https=)
CN (1) CN101801373B (https=)
AU (1) AU2008297608A1 (https=)
BR (1) BRPI0815200A2 (https=)
CA (1) CA2699403A1 (https=)
MX (1) MX2010002754A (https=)
RU (1) RU2361581C2 (https=)
WO (1) WO2009035368A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2361581C2 (ru) 2007-09-14 2009-07-20 Закрытое Акционерное Общество "Мастерклон" Фармацевтическая композиция, обладающая противодиабетической, гиполипидемической, гипогликемической и гипохолестеринемической активностью, способ ее получения и способы лечения указанных заболеваний
RU2421219C1 (ru) * 2009-11-19 2011-06-20 Закрытое Акционерное Общество "Мастерклон" Ингибиторы протеинкиназы с

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3510491A (en) * 1967-02-02 1970-05-05 Sterling Drug Inc 4-(cyclicaminomethyl)-5-hydroxyindole-3-carboxylic acids and esters thereof
US4226829A (en) * 1978-10-04 1980-10-07 Andrew Mike Renewable vaporizer for air treatment and the like
US4889286A (en) * 1988-09-19 1989-12-26 Donald Spector Controllable air freshener unit
FR2674522B1 (fr) * 1991-03-26 1993-07-16 Lipha Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant.
DE19753956A1 (de) * 1997-12-05 1999-06-17 Draeger Sicherheitstech Gmbh Duftpatrone
SE0104334D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
CN100457730C (zh) * 2002-08-29 2009-02-04 默克公司 具有抗糖尿病活性的吲哚化合物
AR041481A1 (es) 2002-10-07 2005-05-18 Hoffmann La Roche Derivados de acido arilpropionico-oxazol y su uso como agonistas de ppar
CA2502269C (en) 2002-10-18 2009-12-22 Merck & Co., Inc. Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
WO2005102320A1 (fr) 2004-04-21 2005-11-03 Zakrytoe Aktsionernoe Obschestvo 'masterklon' Medicament pour traiter des infections virales
US20060233538A1 (en) * 2005-04-14 2006-10-19 Tollens Fernando R Energized systems and devices for delivering volatile materials
WO2007075102A1 (en) 2005-12-28 2007-07-05 Zakrytoe Aktsionernoe Obschestvo 'masterklon' Medicinal agent for treating viral infections
US20070176015A1 (en) * 2006-01-30 2007-08-02 The Procter & Gamble Company System for delivering volatile materials
WO2007136302A2 (en) 2006-05-23 2007-11-29 Alla Chem, Llc Active substances, pharmaceutical composition and a method for the production and use thereof
US8329689B2 (en) 2006-05-23 2012-12-11 Alexandre Vasilievich Ivachtchenko Substituted indoles and a method for the production and use thereof
WO2008100977A2 (en) * 2007-02-14 2008-08-21 N.V. Organon Carbamates therapeutic release agents as amidase inhibitors
RU2344817C1 (ru) 2007-06-19 2009-01-27 Андрей Александрович Иващенко Замещенные эфиры 5-гидрокси-1н-индол-3-карбоновой кислоты, фармацевтическая композиция, способ их получения и применения
RU2361581C2 (ru) 2007-09-14 2009-07-20 Закрытое Акционерное Общество "Мастерклон" Фармацевтическая композиция, обладающая противодиабетической, гиполипидемической, гипогликемической и гипохолестеринемической активностью, способ ее получения и способы лечения указанных заболеваний

Similar Documents

Publication Publication Date Title
TWI694076B (zh) 三唑并嘧啶化合物及其用途
RU2339637C1 (ru) Блокаторы гистаминного рецептора для фармацевтических композиций, обладающих противоаллергическим и аутоиммунным действием
ES2572803T3 (es) Estimuladores de GCs
JP2010509356A5 (https=)
JP2015505296A5 (https=)
JP2014505107A5 (https=)
TW202529768A (zh) 癌症治療的療法
JP2011524422A5 (https=)
JP2011500758A5 (https=)
JP2009536620A5 (https=)
JP2016040288A5 (https=)
JP2014508811A5 (https=)
JP2014511892A5 (https=)
JP2015524472A5 (https=)
JP2006524222A5 (https=)
JP2013509392A5 (https=)
JP2013545823A5 (https=)
JP2014508804A5 (https=)
RU2015101102A (ru) Гетероароматическое метильное производное циклического амина
EP3768666A1 (en) Compounds and methods for ido and tdo modulation, and indications therefor
JP2011509302A5 (https=)
TW200418836A (en) Formulations comprising an indolinone compound
JP2011509301A5 (https=)
JP2013542267A5 (https=)
JP2017519818A5 (https=)